Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Equity Ratio: 2022-2025

Historic Equity Ratio for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to 0.36.

  • Immunocore Holdings' Equity Ratio rose 3.26% to 0.36 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36, marking a year-over-year increase of 3.26%. This contributed to the annual value of 0.36 for FY2024, which is 42.17% down from last year.
  • According to the latest figures from Q3 2025, Immunocore Holdings' Equity Ratio is 0.36, which was up 0.22% from 0.36 recorded in Q2 2025.
  • Immunocore Holdings' 5-year Equity Ratio high stood at 0.64 for Q4 2022, and its period low was 0.35 during Q3 2024.
  • Its 3-year average for Equity Ratio is 0.39, with a median of 0.36 in 2025.
  • In the last 5 years, Immunocore Holdings' Equity Ratio tumbled by 42.17% in 2024 and then climbed by 3.26% in 2025.
  • Quarterly analysis of 4 years shows Immunocore Holdings' Equity Ratio stood at 0.64 in 2022, then dropped by 3.97% to 0.62 in 2023, then plummeted by 42.17% to 0.36 in 2024, then rose by 3.26% to 0.36 in 2025.
  • Its Equity Ratio was 0.36 in Q3 2025, compared to 0.36 in Q2 2025 and 0.37 in Q1 2025.